Hsbc Holdings PLC Takes $11.43 Million Position in Ralliant Corporation $RAL

Hsbc Holdings PLC purchased a new position in shares of Ralliant Corporation (NYSE:RAL) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 154,825 shares of the company’s stock, valued at approximately $11,433,000.

Other large investors also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Ralliant in the 2nd quarter valued at about $1,039,481,000. Viking Global Investors LP bought a new position in Ralliant during the second quarter worth about $257,200,000. State Street Corp bought a new position in Ralliant during the second quarter worth about $213,096,000. Millennium Management LLC increased its stake in shares of Ralliant by 172.4% in the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after purchasing an additional 3,147,660 shares in the last quarter. Finally, Flossbach Von Storch SE purchased a new position in shares of Ralliant in the second quarter worth about $222,460,000.

Insider Buying and Selling at Ralliant

In related news, SVP Karen M. Bick sold 6,062 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the sale, the senior vice president owned 31,668 shares in the company, valued at approximately $2,280,096. This trade represents a 16.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of Ralliant stock in a transaction on Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares of the company’s stock, valued at $18,088,710.93. This represents a 4.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.42% of the company’s stock.

Analyst Upgrades and Downgrades

RAL has been the topic of a number of recent research reports. Royal Bank Of Canada upped their price target on shares of Ralliant from $71.00 to $73.00 and gave the company a “sector perform” rating in a research note on Friday, July 31st. Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a research note on Friday, July 31st. Zacks Research raised shares of Ralliant from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Morgan Stanley boosted their target price on shares of Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a report on Tuesday, June 23rd. Finally, TD Cowen raised their price target on Ralliant from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $75.70.

Ralliant Price Performance

RAL stock opened at $61.65 on Friday. The firm has a 50 day moving average of $68.40 and a 200-day moving average of $56.42. The firm has a market capitalization of $6.82 billion, a P/E ratio of -5.68, a price-to-earnings-growth ratio of 2.35 and a beta of 1.60. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $75.41. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75.

Ralliant (NYSE:RAL) last posted its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The business had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, sell-side analysts predict that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant’s payout ratio is -1.84%.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.